06/08/2026
June is Alzheimer's & Brain Awareness Month
About 1 in 9 Americans age 65 and older is living with Alzheimer's disease, making early recognition and intervention more important than ever.
At Sage Infusion, we're committed to supporting patients and families navigating the challenges of Alzheimer's disease. We offer LEQEMBI® and KISUNLA™ infusions—FDA-approved treatments for eligible individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease.
Knowing the signs early can help patients access treatment options sooner and plan for the future with confidence.
📖 Read our latest health blog: Spotting Alzheimer's Early: Signs, Symptoms, and New Hope
https://sageinfusion.com/2026/06/01/spotting-alzheimers-early-signs-symptoms-and-new-hope/
If you or a loved one are experiencing memory or cognitive changes, talk with your healthcare provider to learn whether these treatment options may be appropriate.